AzTrials
AzTrials

RehabilitationPAMSNCT04186910

In Clinic Physical Activity in Persons With Multiple Sclerosis

A study testing Feedback group in people with Rehabilitation and Multiple Sclerosis, run by Fondazione Don Carlo Gnocchi ETS at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of htis study is to investigate the post intervention effects of daily feedback on actual physical activity levels derived from a wristworn accelerometer FITBIT combined with self-management training on in-clinic physical activity in persons with moderate to severe disability from MS. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Rehabilitation, Multiple Sclerosis
What is being tested?
Feedback group
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
20 participants
Where
1 siteItaly
Study dates
1 Jul 2019to Sep 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosis of MS according to the McDonald's criteria McDonald Criteria 2010
  • EDSS score >4.5-7
  • Freedom from relapses and steroid treatment for at least 1 month
  • Ability to walk at least 10 meters independently with or without support
  • MS without relapses in the last 3 months

Who cannot join

  • Mini Mental State Examination (MMSE) score < 20
  • The presence of disabling pain or severe deficit of visual acuity
  • The presence of severe deficit in communication and severe dysmetry

Trial locations and contacts

1 site in 1 country.

Maria Chiara Carrozza, PhD contact

+390210308 ext. 405

mcarrozza@dongnocchi.it

Marco Rovaris, MD contact

+390210308

mrovaris@dongnocchi.it

Italy1 site, 1 recruiting
  • Fondazione Don Carlo Gnocchi IRCCS

    Milan, 20148

    Johanna Jonsdottir, PhD, +39 0230408, jjonsdottir@dongnocchi.it

    Recruiting

Other trials in Italy

About this study

Official title: Increasing Physical Activity in Recovered Persons With Multiple Sclerosis Through Daily Sensor Based Feedback and Weekly Focus Group Meetings: A Feasibility and Pilot II Study

The aim of htis study is to investigate the post intervention effects of daily feedback on actual physical activity levels derived from a wristworn accelerometer FITBIT combined with self-management training on in-clinic physical activity in persons with moderate to severe disability from MS.

Read the detailed description

Evidence from various sources indicate that physical activities and mobility practice are beneficial to maintain or increase functional levels in persons with Multiple sclerosis. Even so persons with moderate and severe disability from Multiple sclerosis are less active in daily life than their healthy counterparts. Also during hospital stay persons with MS tend to remain relatively sedentary outside of their rehabilitation sessions. Feedback about physical activity enabled by wearable sensors combined with behavioral strategies to improve self-efficacy and motivation are potential method increase physical activity in hospital inpatients. The primary purpose of this feasibility and interventional study was to determine whether a minimalist physical activity tracker-based feedback and self efficacy training would lead to an increase in physical activity, mobility and quality of life measures during recovery in a group of persons with MS compared to a control group that does not receive feedback. Secondary purpose was to verify if this intervention during recovery would lead to increased perceived physical activity in daily home life after discharge and over longer periods (Follow up at 6 weeks). The study participants will be 60 persons that have moderate to severe disability due to MS, that are admitted to MS Centre of the Santa Maria Nascente Institute, Don Gnocchi Foundation (Milan, Italy). Participants will all receive standard rehabilitation offered in the center. All participants will wear the accelerometer device (FitBit Charge tracker, FitBit Inc, CA, USA) 24 hours per day in order to measure physical activity levels during their hospital stay (3-4 weeks. The participants will be randomized to a group that has no feedback of physical activity level and a group that will have an active feedback intervention (AF). The active feedback intervention will consist of daily feedback, received through a Fitbit application downloaded on their telephones, on whether or not their target activity level was met and how far they were from the target. Additionally, the participants will participate in weekly meeting group focused on enhancing behavioral strategies to increase self-efficacy and motivation. Covariates such as age, sex, stage of change for physical activity behavior, clinical mobility, fatigue, health perception and goal commitment will be measured in all 60 participants both pre and post the intervention/hospital recovery period. The long-term effects on daily perceived functional mobility and self-efficacy will be investigated six weeks after discharge through questionnaires during a telephone call.

Being tested
Control group, Feedback group
Keywords
Multiple Sclerosis, Physical activity, Mobility, Self efficacy
Medical subject headings
Multiple Sclerosis, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Control groupBehavioural

    The control group will carry the Fitbit for the entire period of the recovery but will receive no feedback and will not have the app downloaded onto the telephone.

  • Feedback groupBehavioural

    The feedback group will carry the Fitbit for the entire period of the recovery and will receive daily feedback on amount of physical activity carried out and percentage completed of target behavior at the end of the day from an app downloaded on their telephone. The feedback group will also participate in weekly one hour meetings focused on enhancing behavioral strategies to increase self-efficacy and motivation. They will also have their fitbit data analyzed and an agreed upon target of daily activity level increase.

Study groups in NCT04186910
Study groupRoleWhat they receive
Control groupPlacebo comparatorThe control group will not receive any feedback on levels of physical activities but will receive any planned usual care rehabilitation activities
Receives: Behavioral: Control group
Feedback groupExperimentalThe feedback group will have an active feedback intervention of physical activities, consisted of daily feedback, received through a Fitbit application, and weekly meeting group focused on enhancing behavioral strategies to increase self-efficacy and motivation. The experimental group will receive any planned usual care rehabilitation activities.
Receives: Behavioral: Feedback group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of passes with Fitbit wristband

    A Fitbit wristband consists of an accelerometer and a memory unit and is used to collect mobility data, in the form of number of passes. More passes carried out during the period of wearing the wristband the better.

    Measured: Change from number of passes at baseline to number of passes after 4 weeks will be measured.

  2. The 2 minute walking test

    The 2 minute walking test is used to understand functional mobility. A smaller distance covered (in meters) represents a worse outcome.

    Measured: Change on the measue will be measured. Will be applied at Day 1 and after 4 weeks

  3. The Self-Efficacy in Multiple Sclerosis Scale

    The Self-Efficacy in Multiple Sclerosis Scale is a questionnaire of perceived self-efficacy of MS patients

    Measured: Change on the measure will be measured. Will be applied at Day 1, after 4 weeks and after 10 weeks

Secondary outcomes (6)
  1. The 10 meters walking scale

    The 10 meters walking test (10MWT) is a test in which the participant is timed while walking 10m at their comfortable speed. A lower gait velocity represents a worse outcome.

    Measured: Change from Day 1 to day 28 will be measured. Will be applied at the Day 1 and after 4 weeks

  2. The Short Form-12 questionnaire

    The Short Form-12 questionnaire is comprised of two domains, physical and mental and gives two composite scores that reflect the perceived health of the participant (normative score value= 50).

    Measured: Change from Day 1 to 4 weeks and until 10 weeks will be measured. Will be applied at baseline Day 1 after 4 weeks and after 10 weeks

  3. The EQ-5D visual analogue scale

    The EQ-5D visual analogue scale is a measure of health-related quality of life (Minimum score=5, maximum score= 25; higher values represent a worse outcome).

    Measured: Change from Day 1 to 4 weeks and until 10 weeks will be measured. Will be applied at the Day 1, after 4 weeks and after 10 weeks

  4. The Twelve Item MS Walking Scale

    The Twelve Item MS Walking Scale is a questionnaire about the ability to walk (Minimum score=12, maximum score= 60; higher values represent a worse outcome).

    Measured: Change from Day 1 to 4 weeks and until 10 weeks will be measured. Will be applied at the Day 1, after 4 weeks and after 10 weeks

  5. The Fatigue severity Scale

    The Fatigue severity Scale is a questionnaire of perception of fatigue (Minimum score=9, maximum score= 63; higher values represent a worse outcome).

    Measured: Change from Day 1 to 4 weeks and until 10 weeks will be measured. Will be applied at the Day 1, after 4 weeks and after 10 weeks

  6. The Physical Activity Disability Survey-Revised questionnaire

    The Physical Activity Disability Survey-Revised is a questionnaire of physical activity

    Measured: Change from Day 1 to 4 weeks and until 10 weeks will be measured. Will be applied at the Day 1, after 4 weeks and after 10 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Dec 2019
  2. Study start1 Jul 2019
  3. Primary completionJul 2020 (estimated)
  4. Study completionSep 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Two arms interventional single blind pilot study
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04186910
Sponsor's protocol ID
Physical Activity MS
Acronym
PAMS
Status last verified
Jul 2019
First submitted
4 Jul 2019
Last updated
5 Dec 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Due to ethical restrictions set by the Ethics Committee of Fondazione Don Carlo Gnocchi and the presence of identifying patient information, researchers wishing to access raw data for use in future research studies should write to the Corresponding Author/Principal investigator that will apply to the Ethics Committee of Fondazione Don Carlo Gnocchi for approval. Additional data can be made available upon request.

Questions about this trial

What is this clinical trial studying?

A study testing Feedback group in people with Rehabilitation and Multiple Sclerosis, run by Fondazione Don Carlo Gnocchi ETS at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Dec 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Maria Chiara Carrozza, PhD (+390210308 ext. 405, mcarrozza@dongnocchi.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of passes with Fitbit wristband (time frame: Change from number of passes at baseline to number of passes after 4 weeks will be measured.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in